LINC02358

Across TCGA pan-cancer cohorts, LINC02358 RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated LINC02358 data layer.

The strongest signal is observed in uterine carcinosarcoma (UCS), where higher LINC02358 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC02358 expression acts as an unfavorable survival marker, although some lineages such as STAD and LUAD show a favorable association.

UCS, UVM, and UCEC are the cancer types where LINC02358 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCS	DFS	Tertile	All	0.068	0.524	<.001	144	view →
UVM	OS	Tertile	All	0.225	0.865	<.001	126	view →
UCEC	OS	Tertile	II,III,IV	0.204	0.768	.003	72	view →
SKCM	DFS	Tertile	All	0.299	0.627	<.001	51	view →
STAD	DFS	Tertile	III,IV	0.773	0.312	.009	48	view →
ESCA	OS	Tertile	All	0.198	0.872	.003	36	view →
KIRC	DFS	Tertile	All	0.295	0.639	.029	6	view →
LGG	OS	Tertile	All	0.153	0.451	.009	6	view →
LUAD	DFS	Tertile	All	1.000	0.336	.048	3	view →
KICH	DFS	Quartile	II,III,IV	0.292	0.851	.015	1	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

LINC02358–UCS (DFS)

Open the UCS breakdown →